Evidence map›Paper›PMID 38899679›Full record

ArticleUrology practice2024

Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise.

Kristian D Stensland, Madison K Krischak, Merrick Bank, Rishi R Sekar, Patrick Lewicki, Gretchen A Piatt, Khurshid Ghani, Lindsey A Herrel, Geoffrey D Barnes, David D Odell and 1 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kristian D StenslandDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Madison K KrischakDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Merrick BankDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Rishi R SekarDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Patrick LewickiDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Gretchen A PiattDepartment of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan.
Khurshid GhaniDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Lindsey A HerrelDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Geoffrey D BarnesDepartment of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
David D OdellDepartment of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
Ted A SkolarusDepartment of Surgery, University of Chicago, Chicago, Illinois.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
University of Michigan UroEPI Career Development ProgramK12DK111011 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLEMENS, J. QUENTIN, SARMA, ARUNA V · 2016 to 2025
$3.6M
Building capacity for clinical trial improvement through implementation scienceF32CA264874 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STENSLAND, KRISTIAN DONALD · 2021 to 2021
$84k
NCI NIH HHS F32 CA264874NCI NIH HHS P30 CA046592NIDDK NIH HHS K12 DK111011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicMedical OncologyHumansUrologic NeoplasmsUrologycancerclinical trialsenrollment

Identifiers

PMID38899679
PMCPMC11268800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.